Back to compounds
Peptides - Metabolic

Cagrilintide

Long-acting amylin analog that reduces appetite and enhances weight loss when combined with semaglutide

Fat LossHormone OptimizationCompare

Dosage

1.2-2.4mg weekly

Results

4-8 weeks

Frequency

Weekly

Cost

$200-400/month

Administration

Method

Subcutaneous injection

Timing

AM

Food

Any time

Key Benefits

  • Powerful appetite suppression
  • Enhances semaglutide effects
  • Slows gastric emptying
  • Improves glycemic control
  • Long-acting weekly dosing

Stacks Well With

Semaglutide

GLP-1 agonist for weight management and metabolic optimization

Retatrutide

Triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors

Tesamorelin

FDA-approved GHRH analog that targets visceral fat

Important Considerations

  • • Gastroparesis
  • • MEN2
  • • Thyroid cancer history
  • • Pregnancy

Additional Notes

  • • Often combined with semaglutide (CagriSema)
  • • Start low and titrate up
  • • May cause GI side effects initially

Research & Studies

Cagrilintide: Long-Acting Amylin Analog Phase 2

2021·Clinical Trial

Cagrilintide + Semaglutide: REDEFINE 1 Trial

2023·Clinical Trial

Research provided for educational purposes. Always consult a healthcare provider.

Estimated monthly

$200-400